BenevolentAI
of companies in hit target companies can be characterized across two key dimensions original technology focus and drug discovery approach target high complexity through biology many layers of knowledge needed and many areas where research is not yet complete hit high computational complexity figure analysis listed companies only companies also active in the space through internal development and or collaborations hypothesis driven involves a data driven hypothesis led approach to therapeutic target cation non hypothesis driven leverages technology to identify solutions without conditions to target at the outset | BenevolentAI
Company
Deck Type
Deck date
March 2023
Slide
38 of 38
Similar slides by BenevolentAI
Investor Presentation
October 2022
Investor Day
September 2022
Related slides by other companies
SPAC
March 2023
Investor Presentation
October 2023
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Investor Conference
January 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io